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Abstract: The common bean is a nutrient-dense food empirically known to have beneficial effects
on human health. Many studies have looked at the effects of “pulses” on different health issues,
providing general overviews of the importance of each pulse in health studies. This study system-
atically reviews and provides meta-analyses of the effect of bean extract as a supplement or whole
bean on four health issues (cardiovascular diseases, diabetes mellitus, obesity, and cancers) from
a dissection of clinical and randomized controlled trials using human subjects. A digital search in
PubMed and Google ScholarTM resulted in 340 articles, with only 23 peer-reviewed articles matching
our inclusion criteria. Findings indicated that common beans reduced LDL cholesterol by 19 percent,
risk of cardiovascular disease (CVD) by 11 percent, and coronary heart disease (CHD) by 22 percent.
Besides this, we noted variances in the literature on cancer findings, with some authors stating it
reduced the proliferation of some kinds of tumor cells and reduced the growth of polyps, while others
did not specifically examine cancers but the predisposing factors alone. However, diabetes studies
indicated that the postprandial glucose level at the peak of 60 min for common bean consumers was
low (mean difference = −2.01; 95% CI [−4.6, −0.63]), but the difference between the treated and
control was not significant, and there was a high level of heterogeneity among studies (I2 = 98%).
Only obesity studies indicated a significantly high level of weight gain among control groups (mean
difference = 1.62; 95% CI [0.37, 2.86]). There is a need for additional clinical trials using a standardized
measure to indicate the real effect of the common bean on health.
Keywords: common beans; cardiovascular diseases; diabetes mellitus; obesity; cancers; human
trials; health
1. Introduction
Globally, pulses are regarded as nutritional powerhouses and an alternative compo-
nent of healthy diets among poor households [1]. This is especially true for households in
Sub-Sahara Africa (SSA), where it forms the largest part of the diet, with weekly consump-
tions averaged at 4.2 times a week in some countries, such as Uganda [2]. The global per
capita intake of pulses is about 21 g per day, with SSA averaging 33 g per capita per day [3].
This can be as high as 107 g per meal per person for common bean (Phaseolus vulgaris L.)
consumers in Uganda, averaging an annual of 22.41 kg/person [2]. Common beans were
once considered a “poor man’s meat” across many countries in Sub-Saharan Africa [4,5],
because they were not being consumed by the rich. They are the most produced crops, and
are second only to maize in some countries, such as Kenya [6].
In Rwanda, for example, high-iron bean (HIB) varieties developed by the Pan-Africa
Bean Research Alliance (PABRA) are grown by 20 percent of the farmers and consumed by
15 percent of the population (or 1.8 million people), in response to the need for fighting
hidden hunger and malnutrition [7]. Several studies in Rwanda [8–10] demonstrated
that consumption of HIB had cognitive benefits for college students, increased physical
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work efficiency in women, and increased iron status in women after 128 days, respectively.
However, there exist no long-term studies or national-level datasets on the effectiveness of
bio-fortification in increasing iron in common beans with respect to SSA.
Common beans are also lauded as ecologically sustainable protein sources compared
to animal-based ones [11]. Additionally, they have a unique nutrient-rich profile, especially
their high protein content, ranging between 17 and 30 percent dry weight [12]. The high
insoluble fiber in beans also provides slow-digesting carbohydrates and micronutrients
(iron and zinc) that reduce postprandial glucose release, thereby benefiting people with
diabetes. Apart from health, beans are also beneficial economically, especially to women in
SSA, who are disproportionately involved in its production, processing, marketing, and
cooking [13].
Contemporary developments have given rise to rejuvenated interests in epidemio-
logical, clinical, and randomized controlled trial studies that investigate common bean
consumption with respect to health, especially their role in reducing the risks of chronic
cancers, cardiovascular diseases (CVD), diabetes mellitus, and obesity [1,14]. This interest
is pegged on the nutritional capacity of beans given their relatively low cooked-serving en-
ergy density, low-fat content, and high iron and zinc, among other minerals (1.3 kcal/g) [15].
The 50–65 percent carbohydrate content of common beans is slowly digested, further low-
ering the glycemic index (GI) [16]. Furthermore, common beans provide 23–32 g of fiber
per 100 g dry weight, of which 20–28 g is insoluble, highlighting their role as fiber-rich
foods, which can lower the risk of heart disease, stroke, diabetes, and colorectal cancer [17].
Despite the interest in common bean studies, a review of meta-analysis studies that
have delved into pulses in general reveals some interesting study gaps. First, according
to [18], there is a huge gap in studies that use human subjects to examine the effect of
pulses on health. This current study only includes studies that only used human subjects,
which may be desirable for dietary recommendations for humans. Secondly, meta-analysis
studies such as Ferreira et al. [1] and Marventano et al. [19] generally reported on “pulses”
and not specifically on common beans. Thirdly, a mixed use of human subjects and
mice/rats presents a challenge in pinpointing the effect of common beans on human
health. As mentioned above, all mice studies were therefore excluded. Furthermore,
studies such as Onakpoya et al. [20], Padhi and Ramdath [21], Sievenpiper et al. [22], and
Zhu et al. [23] conducted meta-analyses on pulses, focusing on specific health issues such
as CVD and colorectal cancer; prior studies have seldom combined all health issues that
pulses may alleviate. This means such studies present a one-sided story that may limit our
understanding of the full range of benefits of common beans on other health issues. In the
current study, we specifically focus on common beans and include four main health issues
(cancer, CVD, obesity, and diabetes) that have not been combined in other meta-analyses.
We also differ from studies using mice, instead reporting on clinical and RCT trials using
human subjects. This, to the best of our knowledge, has previously not been presented
or analyzed.
2. Materials and Methods
2.1. Search Strategy
We used the Preferred Reporting Items for Systematic reviews and Meta-Analyses
(PRISMA) criteria for the literature review in this study [24]. We first searched the indexed
studies found on Google Scholar with a powerful search query as follows: intext: “common
beans” AND “health” AND “randomized controlled trial” -fruit -herbal -mice filetype:
pdf. The ‘minuses’ excluded fruit and herbal fusions and studies that used mice. Each
time, we iteratively replaced “health” with either of the four health issues and restricted
results to be from 1995 to 2021. The searches were conducted between the dates of 15
March and 15 April 2021. We also searched PubMed with the terms “common beans” and
“health” and applied filters for clinical trials and randomized controlled trials; in each
specific search on the health issue, the term “health” was replaced with “cancer”, “CVD”,
“obesity”, and “diabetes.”
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2.2. Study Selection and Inclusion and Exclusion Criteria
Peer-reviewed articles from reputable journals were included based on the following
criteria: (1) used human subjects and not mice/rats; (2) used common beans as a whole
grain or extract as a sole treatment or as part of a treatment, not “pulses” in general;
(3) written in English; (4) used RCT or clinical trials; (5) not a systemic review or meta-
analysis, editorial, expert opinion, review, or instructive article. Studies that used meta-
analysis were excluded because they used specific criteria for selection, and 90 percent of
them concentrated on a single issue, e.g., CVD. Blogs, web pages, opinion pieces, reports,
and magazine articles were excluded due to a lack of scientific rigor in them. Studies that
combined pulses (for example, common beans and lentils) were excluded because the effect
of a particular grain on human health would be challenging to evaluate in such a situation.
A total of 24 studies were included in our final analysis, as shown in Figure 1 below.
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2.3. Data Extraction
From each paper, data relating to demographic characteristics of the participants
such as author(s) name, year of publication, total participants disaggregated by sex and
treatment (males vs. females and treated vs. control group), body mass index (BMI) in
kg/m2, and age bracket of the participants were first extracted. Furthermore, to understand
the length of the intervention, data on weeks were evaluated, and the daily quantity of
beans in grams (dry weight) per day for whole cooked beans and milligrams per day
for bean extracts (wet weight) were extracted next. The mean difference or percentage
difference in outcomes between the control and treated group was then extracted. The
bean extracts are in milligrams, as their conversion to grams/day (wet weight) would
make them so small and incomparable to the whole bean group. Data were also extracted
in terms of the health issues addressed in this paper, i.e., diabetes, CVD, obesity, and
cancer. The common bean variety used in the study was also extracted. Finally, the study
summary or policy direction was extracted; the summaries are presented in Table 1 under
summary statistics.
2.4. Empirical Estimations and Statistical Tests
In the current study, we use a mixed-method approach and combine descriptive
statistics, forest plot analysis, and random-effects meta-regression. Descriptive statistics are
used to present summaries in Table 1, providing basic information about the variables used
in the datasets and indicating the potential relationships between the variables used in the
study. Forest plots are necessary for the visualization of the mean differences and potential
influences (measured by weights) that each study has in the meta-analysis. Various studies
have used forest plots for meta-analysis [19,23,24,45].However, in this case, we additionally
combined the forest plots with meta-regressions to highlight the effect of the ‘potential
effect modifiers’ or covariates on the mean differences [45].The influence on the relationship
and the residual heterogeneity among intervention effects that are seldom captured by the
explanatory variables are also captured. The first instance is the obvious OLS regression, in
which an estimation of the relationship between the outcome and covariates is estimated
as follows:
ŷi = β0 + β1xi (1)
where yi is the mean difference of study outcomes, β0 and β1 are the coeffeicients, and xi is
a covariate. This can be extended to meta regression, where the outcome is the observed
effect size θk of study k. Thus,
θk = β0 + β1xk + εk + ζk (2)
where the two types of independent errors are εk (the sampling error showing how the
effect size of the studies vary from the true effect) and ζk (denoting that the true effect size
is a subsample of the distribution of effect sizes). The coefficients can be interpreted as unit
changes in covariates as the outcome changes. Following [46], we used the Sidik–Jonkman
method and applied the Knapp–Hartung error adjustment to present robust coefficients.
This is because the widely used DerSimonian–Laird (DL) method assumes that different
studies estimate different, yet related, intervention effects, which has some fundamental
weaknesses [47]. For example, while treatment and testing inefficaciousness should have an
error rate of 5%, in the DL method, the error rate is usually substantially higher in smaller
studies with a smaller sample size like ours. While there are alternatives to meta-regression,
studies have consistently demonstrated that using the Knapp–Hartung method gives better
adjustment to the significant levels and higher power rates [48].
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Table 1. Selected studies that characterize the association between common bean consumption and health.
Study Study Type HealthIssue
Study
Subjects M F Control Treatment Age Wks Qty
Bean













21 21 - - 19–40 4 100 g/day grain navy, pinto







































6 13 - - 60–65 4 35 g/day grain navy
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ophthalmate increased 5.25-fold for navy
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diabetics 7 5 −0.28 −2.48 50–76 0.3 275 g/day grain
white,
cream
Only white ‘Almonga’ rendered a








Diabetes Normalweight 6 6 0.4 −0.5 20–26 0.2 100 mg/day extract navy, pinto
PVE lowered postprandial glucose
+15·4%, insulin +981, and C-peptide
excursions in 30 min.
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Table 1. Cont.
Study Study Type HealthIssue
Study
Subjects M F Control Treatment Age Wks Qty
Bean
















crossover Diabetes Diabetics 10 12 −0.3 −1.6 24–67 8 180 g/day grain navy
Total cholesterol serum (TC) for baked









0 95 −4 −5.5 18–35 16 225 g/day grain pinto, black,kidney
The total area under the curve reduced
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Obesity Obese 17 8 2.6% 3.4% 18–40 4 2000mg/day extract
white
kidney
Weight decreased by 6.0 lbs and waist







Obesity Obese 29 27 0.9% 2.7% 18–65 4.5 2400mg/day extract
white
kidney
Weight decreased by 2.24 kg (an average











21 31 0.1% 3.2% 22–66 12 900 mg/day extract whitekidney
Serum cholesterol decreased by












13 87 1.4% 3.5% 18–60 12 500 mg/day extract whitekidney
The IQP-PV-101 group lost a mean of







Obesity Healthywomen 0 33 +1.1% 0.2% 21.3 6.7 750 g/day extract adzuki
Triglyceride concentrations in the adzuki








Obesity Overweight 17 42 0.5% 3.9% 20–45 4 445 mg/day extract whitekidney
Weight decreased by 2.93 kg and waist
circumference decreased by 4.8 cm.
Nutrients 2021, 13, 3701 7 of 15
Table 1. Cont.
Study Study Type HealthIssue
Study
Subjects M F Control Treatment Age Wks Qty
Bean







crossover Obesity Healthy 10 12 - - 24–67 8 180 g/day grain navy
Serum LDL-C decreased by −5.4 ± 2.3
percent.
Note: CVD—cardiovascular disease; M—male; F—female; Wks—weeks; Qty—quantity of whole bean/extract given; Ctrl—control; g/day—grams per day; sTNFRI/II—tumor necrosis factor-alpha (TNF-alpha)
and its two soluble receptors, sTNFRI and sTNFRII; (SAA)—serum amyloid A protein; RNA—ribonucleic acid; PVE—Phaseolus vulgaris extract; IQP—PV-101 (marketed globally under the Phase 2, Starchlite, and
PhaseLite brands and contains extracts of Phaseolus vulgaris); LDL-C—low-density lipoprotein cholesterol.
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3. Results
3.1. Summary Findings of Studies
Table 1 shows studies and other control covariates of interest that authors have
presented in different papers. The studies ranged from 4 to 8 weeks, with cancer studies
taking the least time, averaging 4 weeks (a month). Participants were given either bean
extracts or whole grains in grams per day in terms of the interventions. On average,
195.82 g/day (dry weight) of cooked whole beans was given to participants. This may be
equivalent to 34 of a cup of cooked common beans per day, except for obesity studies, which
used 1 34 cups of cooked beans per day. Both men and women were used in the studies;
however, almost none of the papers considered gender disaggregation of outcomes.
We also looked at the specific common bean varieties used for the studies. It emerged
that 21 percent of studies seemed to prefer navy, red, and pinto beans for their studies
(calculations not shown in the table). There were cases where different varieties were
combined, and in such cases, navy beans seemed to be used as a priority, followed by pinto
beans. In the United Kingdom and the United States, where most of these studies took place,
navy beans or haricot beans are particularly popular [49]. White beans are also popular
and have high phosphatidylserine levels, which is beneficial to most consumers (ibid).
Specifically, CVD studies preferred navy, pinto, or red bean varieties, or a combination
thereof. Cancer studies used navy, kidney, or pinto, or a combination thereof. Diabetes
studies were diverse in terms of bean varieties used, while obesity studies seemed to prefer
white kidney beans.
3.1.1. Common Beans and Cardiovascular Diseases (CVD)
For studies that looked at common beans and their effects on CVD, three papers
were particularly vital. First, [25] used the largest sample size for people with no CVD
at the beginning and registered 3680 incidents of CVD after a 19-year follow-up. The
authors found that those who consumed dry beans such as pinto and red beans had an
11 percent lower rate of CVD. Furthermore, [27] found that 180 g/day (dry weight) of
bean consumption reduced the mean serum total cholesterol by 19 percent. However,
Cryne et al. [26], having administered 12 cup of beans per day, failed to find any significant
difference in serum lipids, homocysteine, or glycemic parameters, meaning that beans are
not biomarkers of CVD risk.
a. Common beans and cancers
The five studies evaluated for cancers concentrated on different types, especially
colorectal and breast cancer and other tumors associated with cancers (Table 1). First, Hart-
man et al. [28] administered 251 g/day (dry weight) of whole beans for men characterized
for colorectal adenomas. The authors found that soluble tumor necrosis factor-alpha recep-
tor I and II (sTNFRI/II) concentrations declined marginally during the legume diet period
(23.8%; p = 0.060). This implies that TNFRII directly promoting the proliferation of some
kinds of tumor cells reduced with bean consumption. On the other hand, Perera et al. [29]
found elevated serum pipecolic acid and S-methyl cysteine (which combats the growth of
polyps, i.e., abnormal cell growth that can eventually become malignant) after dry bean
consumption. Using 35 g/day (dry weight) of navy beans, Baxter et al. [45] found that
relative stool abundance of ophthalmate increased 5.25-fold, meaning that cancer con-
trol mechanisms such as detoxification of xenobiotics, antioxidant defense, proliferation,
and apoptosis were enhanced by common bean consumption. Borresen et al. [31] found
serum amyloid A (SAA) levels after bean consumption at week 4 to be high enough to be
associated with colorectal cancer chemoprevention.
b. Common beans and diabetes
Seven studies reported postprandial glucose and insulin levels within 30, 60, 90,
and 120 min after bean consumption, as shown in Table 1. The mean peak glucose
level for most studies was reported at 60 min; therefore, we derived mean differences
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in the fasting glucose level at that number of minutes across all eight studies. First, Nils-
son et al. [33] reported that administration of 101 g/day (dry weight) of brown beans
lowered blood glucose (215%, p < 0.01) and insulin (216%, p < 0.05) at the peak levels.
The authors concluded that brown beans had some colonic substrates that may prevent
obesity and metabolic syndrome through glucose regulation. On the other hand, Olmedilla-
Alonso et al. [34] found the maximum glucose level after 60 min to be almost the same for
the two varieties of beans used, where Almonga had 149.8 ± 28.8 mgdL−1 and Curruquilla
had 145.3 ± 22.4 mgdL−1, while the maximum insulin concentration for Almonga was
33.2 ± 34.7 µlU/mL. The insulin concentrations were 2.48 times lower than the control
group (−0.28), which had white bread. Using a new, standardized, and purified common
bean extract (PVE), Spadafranca et al. [35] found a significantly lower percentage (15.4) of
blood glucose compared to the placebo group. The authors also found insulin increased in
percentage less after PVE supplementation than after placebo (+981 (SEM 115) vs. 1325
(SEM 240). On the other hand, Reverri et al. [36] found that after 60 min, postprandial
blood glucose peaks were lower by 0.2 mmol/L for those who consumed black beans, and
reduced postprandial insulin concentrations were also reported. Kazemi et al. [38]) found
the pulse-based group to have a greater reduction in total area under the curve for insulin
response (mean change −121.0 ± 229.9 vs. −27.4 ± 110.2 µIU/mL × min; p = 0.05). The
authors concluded that pulse-based diets reduce cardio-metabolic disease (e.g., diabetes
mellitus) risk factors in women with polycystic ovary syndrome (PCOS). Thompson [39]
reported that net change glucose responses were significantly lower for the pinto, black,
and dark red kidney bean and rice meals compared to control at 90, 120, and 150 min
post-treatment (p < 0.05). The author recommended a bean and rice mixture for controlling
Type II diabetes. However, [37] found no significant differences in glucose levels between
the treated and the placebo group.
c. Common beans and obesity
Seven obesity studies were reviewed. The mean weight loss/gain due to consumption
of common bean grain or extract was derived. Udani and Singh (2007) found that, after
consuming bean extract, the treatment group lost 6.0 lbs (or 2.7 kg) (p = 0.0002) and
2.2 inches in waist size (p = 0.0050), while the placebo group lost 4.7 lbs (or 2.1 kg) compared
to the baseline.
On the other hand, Wang et al. [14] found that those who consumed PVE had an
average weight loss of 2.24 kg (2.7%), compared to only 0.29 kg (0.3%) for the placebo
group. Birketvedt et al. (2004) found that the supplement group had a significant reduction
in body weight of −3.2 ± 3.4 kg, whereas the placebo group only had a −0.2 ± 2.3 kg
reduction. In another study by Grube et al. [42] with 57 obese subjects, the treatment
group had a mean weight loss of 3.02 ± 62.97 kg, while the placebo group lost a mean of
1.22 ± 62.36 kg (p = 0.027). Maruyama et al. [43] found that the 10 individuals who took
the control juice gained 0.6 kg in weight compared to the 0.1 kg weight loss of the group
that took the concentrated adzuki juice. Celleno et al. [44] found that the body weight (kg)
of those who took the bean extract decreased by −2.93 ±1.6 kg, whereas the placebo group
lost −0.35 ± 0.38 kg (p < 0.001). The final study evaluated by Winham and Hutchins [37]
found no significant differences in weight change over the two treatment periods for the
treated and the placebo group. However, the authors reported a decrease in serum low-
density lipoprotein cholesterol (LDL-C) by −5.4 ± 2.3 percent, possibly indicating that
beans reduce LDL-cholesterol (which can lead to obesity).
3.1.2. Empirical Estimations
a. Forest plot analysis (obesity and diabetes studies)
Figure 2 shows a forest plot. Column 1 shows the studies that were included, while
columns 2 and 3 show the mean differences and standard deviations of postprandial
glucose level after 60 min for the diabetes studies. The mean body weight reduction (as
percentages) for the participants after consuming whole beans or their extracts are also
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presented. The forest plot also shows the confidence intervals of several studies represented
by the whiskers (e.g., 95% CI), while the boxes represent the weight given to the study.
In addition, weights (as percentages) indicating the contribution of an individual study on
the pooled result are presented, where studies with bigger sample sizes and a narrower
confidence interval (CI) correspond to a higher percentage weight and a larger box.




Figure 2. Forest plot empirical estimation of study impact for diabetes and obesity health issues. 
The horizontal red “line of null effect” for these studies indicates that most of the 
studies crossed the line, meaning they had little to no effect and do not illustrate a statis-
tically significant result. The diamond shape indicates the general significant effect of the 
studies combined. 
The diabetes studies seem to indicate a non-significant reduction in glucose levels 
(the horizontal tip of the diamond crosses the vertical line). It is worth noting that most 
diabetes studies show that common bean consumption (whether extract or whole grain) 
effectively reduces postprandial glucose levels among the treated group because the CIs 
are entirely on the negative side and favor the treated group. Overall, the diabetes studies’ 
results indicate a medium treatment effect (mean difference = −2.01), 95% CI [−4.6, −0.63]). 
The Q statistic (Q = 70.06, df = 6) indicated that across the diabetes studies, the effect sizes 
differed significantly. While the I2 of 98% suggests a high level of heterogeneity, and given 
the rule of thumb that less than 50% is desirable, we may conclude that the interventions 
or exposure were not consistent across all the studies, or a random-effects meta-regression 
may be needed to discern the effects of individual covariates. The high heterogeneity may 
be attributable to the small sample size of the studies we found, the type of common beans 
used, and perhaps the researchers’ own biases and problems with data collection. The 
observed variances can also be attributable to differences at the study level. The T2 of 10.62 
suggests a medium amount of absolute dispersion. Following the suggestions of Baker et 
al. [45], higher heterogeneity (variation in results across studies) may require a meta-re-
gression to see the effect of each covariate on the outcome. Given the small number studies 
(low sample size), it is our opinion that conclusions from such regressions would be useful 
Figure 2. Forest plot empirical estimation of study impact for diabetes and obesity health issues.
The horizontal red “line of null effect” for these studies indicates that most of the
studies crossed the line, meaning they had little to no effect and do not illustrate a statisti-
cally significant result. The diamond shape indicates the general significant effect of the
studies combined.
The diabetes studies seem to indicate a non-significant reduction in glucose levels
(the horizontal tip of the diamond crosses the vertical line). It is worth noting that most
diabetes studies show that common bean consumption (whether extract or whole grain)
effectively reduces postprandial glucose levels among the treated group because the CIs
are entirely on the negative side and favor the treated group. Overall, the diabetes studies’
results indicate a medium treatment effect (mean difference = −2.01), 95% CI [−4.6, −0.63]).
The Q statistic (Q = 70.06, df = 6) indicated that across the diabetes studies, the effect sizes
differed significantly. While the I2 of 98% suggests a high level of heterogeneity, and given
the rule of thumb that less than 50% is desirable, we may conclude that the interventions
or exposure were not consistent across all the studies, or a random-effects meta-regression
may be needed to discern the effects of individual covariates. The high heterogeneity may
be attributable to the small sample size of the studies we found, the type of common beans
used, and perhaps the researchers’ own biases and problems with data collection. The
observed variances can also be attributable to differences at the study level. The T2 of
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10.62 suggests a medium amount of absolute dispersion. Following the suggestions of
Baker et al. [45], higher heterogeneity (variation in results across studies) may require a
meta-regression to see the effect of each covariate on the outcome. Given the small number
studies (low sample size), it is our opinion that conclusions from such regressions would
be useful but not generalizable. The studies conducted by Olmedilla-Alonso et al. [34] and
Reverri et al. [36] seem to have the largest impact, due to their narrow CI.
On the other hand, the obesity studies seem to favor the control group, but in the
true sense, it suggests that they had the largest weight gain with medium treatment effect
(mean difference = 1.62), 95% CI [0.37–2.86]). The study desired to observe reduced weight
among the participants. However, we cautiously present the mean difference, as it may
not represent the true mean of the reduction in body weight due to the high heterogeneity
(I2 = 94%). Instead, following Baker et al. (2009), the range of mean differences for the
studies whose means fall within the 0.37 and 2.86 CI may offer insight into the effect of
common beans on weight loss. The CI indicates that the true mean value that other studies
might find for the effect of the common bean on weight gain/loss lies between 0.37 and
2.86. The weight loss is not significant but suggests that common beans may be used to
control obesity. The Q-statistic (Q = 348.27, df = 6, p < 0.001) indicates that across the studies
on obesity, the effect sizes differ significantly. The first three studies by Celleno et al. [44],
Grube et al. [42], and Wang et al. [14] are given weights as 8.05, 7.94, and 8.07, respectively.
The mean difference of weight in favor of the control group is between 1.8 kg and 3.4 kg.
Basically, it may be assumed that consuming common bean extract (for example, capsules
made from beans or concentrated bean juices) for 4–12 weeks has a weight loss effect of
between 1.8 and 3.4 kg. However, the difference between the treated and the control group
is not significant. We may attribute the non-significant difference to non-standardized
measures of common beans (extracts vs. whole beans).
b. Random-effects meta-regression
The meta-regression was run with the mean differences in outcomes (postprandial
glucose level after 60 min and mean weight loss) as the dependent variables and age, weeks
of the study, and quantity of beans consumed as the potential predictors.
As indicated in Table 2, while age may be strongly prognostic, we found evidence that
an increase in age by one year was associated with the likelihood of increased obesity by up
to 0.19 kg. However, it had a negative effect on diabetes, although the difference was not
significant. This may be associated with the fact that the mean age for diabetics was 38 years
(younger populations), and studies have found the onset of diabetes to be about 45 years [49].
Perhaps the authors used younger populations that may not reflect the potential effect of age
on diabetes using common bean as a control. On the other hand, the number of weeks of
the study seemed to significantly reduce the mean outcomes for both obesity and diabetes.
This is counter-intuitive and may be explained by the fact that most of the studies had no
follow-ups or repeated the treatment after some time to observe if treatment and no other
factors significantly affected the outcomes. After accounting for age, weeks, and quantity of
common bean consumed, we found the remaining between-study residual heterogeneity to
be roughly I2 = 56.78% for diabetes studies and I2 = 38.37% for obesity studies.
Table 2. Meta-regression with mean differences as dependent variables and the moderators as predictors.
Obesity Diabetes
Moderators β SE t p > z 95% Conf. Interval β SE Z p > z 95% Conf. Interval
Age 0.19 0.05 3.50 0.07 −0.04 0.42 −0.13 0.05 −2.56 0.13 −0.35 0.09
Number of weeks −0.26 0.09 −2.97 0.10 −0.65 0.12 −0.19 0.09 −2.07 0.17 −0.59 0.21
Quantity of beans −0.001 0.001 −4.22 0.05 −0.003 0.001 0.02 0.01 1.72 0.23 −0.03 0.07
Constant −1.14 1.53 −0.75 0.53 −7.74 5.45 1.20 2.02 0.60 0.61 −7.47 9.87
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4. Discussion and Conclusions
In our analysis of 23 papers linking common bean consumption to four health out-
comes (cardiovascular diseases, diabetes mellitus, obesity, and cancers), some interesting
outcomes relating to regular bean consumption were observed. First, common beans
have been demonstrated to reduce LDL cholesterol by 19 percent and lower CVD rates by
11 percent. Perhaps the work of Bazzano et al. [25] using pinto and red bean varieties may
be reliable because it demonstrated a 22 percent reduction of coronary heart disease (CHD)
and 11 percent reduction of cardiovascular disease (CVD). However, the remaining studies
differed in terms of the percentage reduction, and the figures failed to be as near as possible
to each other, as should happen in RCTs. This may not be surprising given the different
bean varieties used (differing in terms of their nutrient content), the agro-ecological zones,
the subjects evaluated, and more importantly, the form of common bean administered
(extracted or whole grain). Evidently, common beans may only be an option, but not the
ultimate solution, for reducing bad fats that directly lead to fat accumulation, which is a risk
factor for heart disease. Therefore, common beans can be recommended as a component
in diets but may need to be standardized in terms of the daily dose to give people within
a given weight range and, most importantly, the variety of common beans to use. In our
case, pinto and navy beans may be recommended because they seem to have potential for
reducing CVD.
On the other hand, cancer studies were a bit haphazard with respect to studying
how common beans affect colorectal adenomas and the proliferation of some kinds of
tumor cells and how beans reduce the growth of polyps. Just like in CVD, there was a
general lack of specificity for the type of cancer targeted. Even though colorectal and breast
cancer received a fair share of studies, other more dangerous types of cancers (such as
throat cancer) were not included. Perhaps the work of Ombra et al. (2016) that analyzed
extracted cancer cells and indicated that 10 g of bean consumption may be capable of
inhibiting the proliferation of human epithelial colorectal adenocarcinoma (Caco-2) cells,
breast cancer cells, and non-small-cell lung cancer (NSCLC) cells should set an example for
works relating to common beans and health. However, since it was not conducted in RCT
or clinical trials, we could not include it. To date, cancer studies may be concluded to be
underdeveloped and may not demonstrate whether common beans reduce the likelihood
of getting cancers. Further research is required.
Diabetes and obesity studies seem to have more developed discourses regarding
common bean and health research. While various studies have demonstrated that post-
prandial glucose levels at the peak of 60 min were lower for bean consumers, the per-
centage reduction was most of the time not significantly different. For example, while
Spadafranca et al. [35] found a significantly lower percentage (15.4 percent) of blood glu-
cose, Winham and Hutchins [37] found no significant differences. Understandably, the bean
variety used, number of subjects, and type of bean consumed (extract or whole) may have
influenced the study outcomes, but the 15 percentage difference clearly demonstrates that
the non-standardized approach leads to counterintuitive results. Nevertheless, the forest
plot (Figure 1) shows that common bean consumption clearly favors the treated group,
although there is no significant difference. This may mean that common bean consumption
may not be used as a stand-alone recommended diet for glucose control, but as an option
for more controlled glucose release after meals by the body. This is demonstrated in most
studies, especially the slow release of glucose that may be beneficial to diabetic patients.
Finally, the obesity studies demonstrate a mean weight reduction of 3.9 percent
within 4 weeks (Celleno et al., 2007). Clearly, if we look at the 2.93 kg weight loss by
Celleno et al. [44] and the 2.24 kg loss by Wang et al. [14] over 4 weeks, then common
beans may be more beneficial for weight loss compared to the other health issues we
looked into. In fact, this is in concordance with the National Institute of Health [50]
recommendation of 0.45 to 0.90 kg weekly weight loss that may not be detrimental to
human health. Common beans are evidently important in weight loss, but again, the
non-standardized bean varieties and form of bean administered may pose challenges for
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nutritional recommendations. Unless a standardized measure in terms of the form of bean,
the number of times consumed, the quantity consumed, and the variety used (among
others) are standardized, it would be hard to indicate the effect of beans on health.
Future studies should focus on standardization of measurements for common beans
to be consumed and an increased number of participants, in order to provide recommen-
dations for public nutrition policies that target the use of common beans as an alternative
component in a healthy diet. Currently, studies have not yet achieved this.
5. Limitations
Our analysis faced challenges similar to Bazzano et al. [25], especially the fact that very
few studies have evaluated common beans and their effect on health using human subjects.
While the information for bean intake was available, measurements were not standardized,
and common bean varieties differed significantly from study to study. It was not surprising
that measurement error was inevitable for diabetes and obesity studies. Furthermore, the
lack of standardized measures for cancers and CVD meant that mean reduction could not
be observed, and group comparison became impossible or cumbersome. Similarly, we
faced limitations in terms of sufficient data to conduct a dose–response meta-analysis, just
like Zhu et al. [32]. It is possible that other unreported confounders affected the participants
and thus the difference in mean outcomes. These confounders may be socio-economic
and psychologically determined, but the authors did not consider them. Nevertheless,
the use of covariates such as age and sex may still partially reveal the effect of beans on
the sampled health variables. Moreover, our study did not include observational studies
that could potentially provide a retrospective view as argued by Faraoni and Schaefer [51].
However, observational studies are a bit cumbersome to measure—for example, the post-
prandial glucose level after 60 minutes. Our intention was to get measurable and repeatable
analyses that would be devoid of the opinions, biases, and judgements that characterize
observational studies.
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